| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.5 | 0.2 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.2 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |